PMID- 10073673 OWN - NLM STAT- MEDLINE DCOM- 19990325 LR - 20141120 IS - 0033-7587 (Print) IS - 0033-7587 (Linking) VI - 151 IP - 3 DP - 1999 Mar TI - Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins. PG - 343-53 AB - This study was designed to evaluate the antioxidant effect of probucol on peroxidation of low-density lipoproteins (LDLs) initiated by oxygenated free radicals (O2*-) and ethanol-derived peroxyl radicals (RO2*) generated by gamma radiolysis. Initial radiolytic yields related to the markers of lipid peroxidation [i.e. decrease in endogenous alpha-tocopherol, formation of thiobarbituric acid-reactive substances (TBARS) and conjugated dienes] were determined as a function of LDL concentration (1.5 and 3 g l(-1), expressed as total LDL) and in the absence or the presence of probucol at different concentrations (2.3 x 10(-6), 3.5 x 10(-6), 9 x 10(-6) and 20.5 x 10(-6) mol l(-1)). Our results showed that probucol was able to decrease not only the yields of TBARS and conjugated dienes but also the levels of these peroxidation products obtained at high doses (2500 Gy) compared to LDLs without probucol. Under our conditions, probucol displayed an optimal antioxidant effect for an initial concentration in LDLs equivalent to 15 probucol molecules per LDL particle, which corresponded to a pharmacologically relevant concentration of probucol. Moreover, our data showed that probucol was unable to react with RO2* and thus did not protect LDL vitamin E from free radical attack. In addition, the scavenging capacity of probucol on O2*- appeared to be very poor, and probucol more likely reacted with LDL intermediate radical products. Finally, a very significant steady-state level of probucol remained in LDLs at high doses (up to 2500 Gy), equivalent to at least 40% of the initial concentration of probucol. This addressed the question of a mechanism for regeneration of probucol in LDLs. Our results as a whole suggested that the antioxidant effect of probucol in vivo could not be explained by its scavenging capacity with regard to RO2*/O2*- free radicals. FAU - Bonnefont-Rousselot, D AU - Bonnefont-Rousselot D AD - Laboratoire de Biochimie, Hopital de la Salpetriere, Paris, France. FAU - Segaud, C AU - Segaud C FAU - Jore, D AU - Jore D FAU - Delattre, J AU - Delattre J FAU - Gardes-Albert, M AU - Gardes-Albert M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Radiat Res JT - Radiation research JID - 0401245 RN - 0 (Anticholesteremic Agents) RN - 0 (Antioxidants) RN - 0 (Free Radical Scavengers) RN - 0 (Free Radicals) RN - 0 (Lipoproteins, LDL) RN - 0 (Solutions) RN - 0 (Thiobarbituric Acid Reactive Substances) RN - 059QF0KO0R (Water) RN - 11062-77-4 (Superoxides) RN - 1406-18-4 (Vitamin E) RN - 3K9958V90M (Ethanol) RN - P3CTH044XJ (Probucol) SB - IM MH - Anticholesteremic Agents/pharmacology MH - Antioxidants/*pharmacology MH - Ethanol/pharmacology MH - Free Radical Scavengers/pharmacology MH - Free Radicals/metabolism/radiation effects MH - Gamma Rays MH - Humans MH - In Vitro Techniques MH - Kinetics MH - Lipid Peroxidation/*drug effects/*radiation effects MH - Lipoproteins, LDL/*metabolism/*radiation effects MH - Probucol/*pharmacology MH - Radiochemistry MH - Solutions MH - Superoxides/metabolism/radiation effects MH - Thiobarbituric Acid Reactive Substances/metabolism MH - Vitamin E/metabolism/radiation effects MH - Water EDAT- 1999/03/12 00:00 MHDA- 1999/03/12 00:01 CRDT- 1999/03/12 00:00 PHST- 1999/03/12 00:00 [pubmed] PHST- 1999/03/12 00:01 [medline] PHST- 1999/03/12 00:00 [entrez] PST - ppublish SO - Radiat Res. 1999 Mar;151(3):343-53.